INHIBITION OF FLT3 SIGNALING BOTH IN VITRO AND IN VIVO BY AC220, A SECOND GENERATION POTENT AND SELECTIVE FLT3 INHIBITOR

被引：0
|
作者：
Armstrong, R. [1 ]
Gunawardane, R. [1 ]
Rooks, A. [1 ]
Dao, A. [1 ]
Ricono, J. [1 ]
Brigham, D. [1 ]
Zarrinkar, P. [1 ]
Belli, B. [1 ]
Wierenga, W. [1 ]
机构：
[1] Ambit Biosci, San Diego, CA USA
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [21] Diverse Histopathologic and Molecular Responses of Acute Myeloid Leukemia to the FLT3 Inhibitor Quizartinib (AC220)
    Nybakken, Grant E.
    Watt, Christopher
    Morrissette, Jennifer J. D.
    Bagg, Adam
    Carroll, Martin
    Perl, Alexander E.
    BLOOD, 2012, 120 (21)
  • [22] FLT3 Inhibitor AC220 Is a Potent Therapy for Myeloproliferative Disease in c-Cbl RING Finger Mutant Mice
    Langdon, Wallace Y.
    Dagger, Samantha A.
    Taylor, Samuel J.
    Thien, Christine B. F.
    Wikstrom, Matthew E.
    BLOOD, 2011, 118 (21) : 294 - 294
  • [23] Identification and Characterization Of a Potent FLT3 Inhibitor
    Chen, Yun
    Guo, Yao
    Ho, Wanting
    Joe, Zhizhuang
    Zhao
    BLOOD, 2013, 122 (21)
  • [24] Mechanisms of FLT3 inhibitor resistance by FLT3 double mutations
    Katayama, Kazuhiro
    CANCER SCIENCE, 2025, 116 : 1554 - 1554
  • [25] A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220
    Hou, Panpan
    Wu, Chao
    Wang, Yuchen
    Qi, Rui
    Bhavanasi, Dheeraj
    Zuo, Zhixiang
    Dos Santos, Cedric
    Chen, Shuliang
    Chen, Yu
    Zheng, Hong
    Wang, Hong
    Perl, Alexander
    Guo, Deyin
    Huang, Jian
    CANCER RESEARCH, 2017, 77 (16) : 4402 - 4413
  • [26] Catastrophic Eruptive Keratoacanthomas and Squamous Cell Cancers After Treatment With an FLT3 Inhibitor Quizartinib (AC220)
    Altman, Kirstin
    Sharata, Harry
    DERMATOLOGIC SURGERY, 2015, 41 (04) : 530 - 531
  • [27] Differential flt3 mutational status in acute myeloid leukemia predicts sensitivity to flt3 inhibitor gilteritinib in vitro and in vivo
    John, Bincy
    Sundaramoorthy, Pasupathi
    Rainbolt, Elizabeth
    Wong, Andrew
    Ward, Zachary
    Avery, Justin
    Todd, Savannah
    Kidder, Shasta
    Gietl, Diana
    Hall, Chassidy
    Harris, David
    CANCER RESEARCH, 2023, 83 (07)
  • [28] Bone Marrow Stromal Cells Protect Both FLT3-ITD and FLT3-WT Primary AML Cells from the Anti-Leukemic Activity of the FLT3 Inhibitor AC220
    Dos Santos, Cedric
    Ndikuyeze, Georges Habineza
    Nisssan, Michael
    Zhou, Chenghui
    Shan, Xiaochuan
    Perl, Alexander E.
    Carroll, Martin P.
    Danet-Desnoyers, Gwenn
    BLOOD, 2014, 124 (21)
  • [29] Characterization of Potent and Well Tolerated Second Generation FLT3 Inhibitors
    Ciomei, M.
    Amboldi, N.
    Cribioli, S.
    Donati, D.
    Fraietta, I.
    Galvani, A.
    Nuccio, C.
    Pesenti, E.
    Romero, G. Texido
    Borgia, A. Lombardi
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 167 - 167
  • [30] Crenolanib: A next generation FLT3 inhibitor
    Galanis, Allison
    Rajkhowa, Trivikram
    Muralidhara, Chaitanya
    Ramachandran, Abhijit
    Levis, Mark
    CANCER RESEARCH, 2012, 72
12345